Katherine P Liao Selected Research

Katherine P Liao Research Topics

Disease

32	Rheumatoid Arthritis 11/2021 - 03/2009
9	Inflammation (Inflammations) 10/2021 - 10/2013
6	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2018 - 08/2013
5	Cardiovascular Diseases (Cardiovascular Disease) 11/2021 - 11/2015
4	Genetic Risk Score 11/2021 - 01/2011
3	Hyperlipidemias (Hyperlipidemia) 10/2018 - 04/2015
3	Crohn Disease (Crohn's Disease) 04/2016 - 08/2013
3	Ulcerative Colitis 04/2016 - 08/2013
2	Neoplasms (Cancer) 09/2021 - 05/2014
2	Chondrocalcinosis (Pseudogout) 01/2021 - 06/2018
2	Arthritis (Polyarthritis) 02/2020 - 11/2016
2	Colorectal Neoplasms (Colorectal Cancer) 01/2016 - 05/2014
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022
1	Sickle Cell Trait 01/2022
1	Colonic Neoplasms (Colon Cancer) 01/2022
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2021
1	Peripheral Arterial Disease 10/2021
1	Arteritis 06/2021
1	Sudden Infant Death (SID) 01/2021
1	Synovitis 01/2021
1	Ankylosing Spondylitis 01/2020
1	Infections 01/2020
1	Sacroiliitis 01/2020
1	Spondylitis 01/2020
1	Non-Radiographic Axial Spondyloarthritis 11/2019
1	Insulin Resistance 01/2018
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018
1	Atherosclerosis 01/2018
1	Arthralgia (Joint Pain) 01/2018
1	Obesity 01/2017
1	Hypertension (High Blood Pressure) 05/2016
1	Diabetes Mellitus 01/2016
1	Sclerosing Cholangitis 01/2016
1	Dyslipidemias (Dyslipidemia) 11/2015
1	Autoimmune Diseases (Autoimmune Disease) 01/2015
1	Heart Diseases (Heart Disease) 10/2013
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 03/2009

Drug/Important Bio-Agent (IBA)

10	LipidsIBA 01/2021 - 12/2013
9	LDL CholesterolIBA 01/2021 - 06/2014
6	Antirheumatic Agents (DMARD)IBA 06/2021 - 02/2015
6	LDL Lipoproteins (beta Lipoproteins)IBA 01/2021 - 06/2014
5	Tumor Necrosis Factor InhibitorsIBA 06/2021 - 01/2018
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 11/2015
4	oxidized low density lipoproteinIBA 10/2018 - 06/2014
3	Biomarkers (Surrogate Marker)IBA 11/2021 - 08/2019
3	C-Reactive ProteinIBA 10/2021 - 01/2017
3	Biological ProductsIBA 01/2020 - 01/2013
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2016 - 01/2016
3	Vitamin D FDA LinkGeneric 11/2015 - 08/2013
2	Hemoglobins (Hemoglobin)IBA 01/2022 - 01/2016
2	Methotrexate (Mexate)FDA LinkGeneric 11/2021 - 05/2016
2	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 10/2021 - 01/2018
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2021 - 08/2019
2	Calcium PyrophosphateIBA 01/2021 - 06/2018
2	Infliximab (Remicade)FDA Link 01/2020 - 04/2016
2	Adalimumab (Humira)FDA Link 01/2020 - 04/2016
2	CholesterolIBA 01/2018 - 11/2015
2	AntibodiesIBA 01/2018 - 03/2015
2	Fibrinogen (Factor I)FDA Link 01/2018 - 01/2017
2	HDL LipoproteinsIBA 01/2017 - 01/2015
2	AutoantibodiesIBA 01/2017 - 03/2013
2	Antihypertensive Agents (Antihypertensives)IBA 05/2016 - 01/2016
2	SteroidsIBA 04/2016 - 10/2013
2	Monoclonal AntibodiesIBA 04/2016 - 01/2016
2	HDL CholesterolIBA 11/2015 - 01/2015
2	Lipoproteins (Lipoprotein)IBA 01/2015 - 12/2013
2	Proteins (Proteins, Gene)FDA Link 01/2015 - 01/2013
2	hydroxide ionIBA 05/2014 - 08/2013
1	P-2 (P 2)IBA 01/2022
1	Immune Checkpoint InhibitorsIBA 09/2021
1	Immunologic Factors (Immunomodulators)IBA 06/2021
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2021
1	Troponin T (Troponin T1)IBA 01/2021
1	Biosimilar PharmaceuticalsIBA 02/2020
1	Etanercept (Enbrel)FDA Link 01/2020
1	Abatacept (Orencia)FDA Link 01/2020
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2020
1	Type II Tumor Necrosis Factor ReceptorsIBA 08/2019
1	Janus Kinase InhibitorsIBA 01/2018
1	CytokinesIBA 01/2018
1	vedolizumabIBA 01/2018
1	serum P-component (CIt)IBA 01/2018
1	Fibronectins (Fibronectin)IBA 01/2017
1	AntigensIBA 01/2017
1	EpitopesIBA 01/2017
1	Leflunomide (Arava)FDA LinkGeneric 05/2016
1	Prednisone (Sone)FDA LinkGeneric 04/2016
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 04/2015
1	Peptides (Polypeptides)IBA 03/2015
1	Anti-Citrullinated Protein AntibodiesIBA 03/2015
1	Pharmaceutical PreparationsIBA 01/2015
1	GoldIBA 07/2011
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2011
1	cyclic citrullinated peptideIBA 03/2009

Therapy/Procedure

8	Therapeutics 01/2022 - 10/2013
1	Colectomy 01/2022
1	Immunotherapy 09/2021